Lupus erythematosus.
D000974:Antibodies, Antinuclear; D003276:Contraceptives, Oral / Q000009:adverse effects; D004247:DNA; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007181:Inclusion Bodies, Viral; D008179:Lupus Erythematosus, Discoid / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy; D008297:Male; D008854:Microscopy, Electron; D009976:Orthomyxoviridae Infections / Q000150:complications; D011342:Procainamide / Q000009:adverse effects; D012313:RNA; D012867:Skin / Q000276:immunology / Q000473:pathology; D012882:Skin Tests; D014466:Ultraviolet Rays
D000974:Antibodies, Antinuclear; D003276:Contraceptives, Oral; D012313:RNA; D004247:DNA; D011342:Procainamide